GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Long-Term Debt

PharmaTher Holdings (XCNQ:PHRM) Long-Term Debt : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Long-Term Debt?

PharmaTher Holdings's Long-Term Debt for the quarter that ended in Feb. 2024 was C$0.00 Mil.


PharmaTher Holdings Long-Term Debt Historical Data

The historical data trend for PharmaTher Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Long-Term Debt Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Long-Term Debt
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaTher Holdings  (XCNQ:PHRM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


PharmaTher Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines